Why the study?
Does therapeutic heparinization enhance fibrinolysis in patients suspected of pulmonary embolism?
Does therapeutic heparinization enhance fibrinolysis in patients suspected of pulmonary embolism?
Therapeutic heparinization increases tPA levels in patients suspected of pulmonary embolism but does not lead to enhanced fibrinolysis.
Answers are grounded in this paper and cite their sources.
Questions assumption of heparin-enhanced fibrinolysis in suspected PE; leaves open outcome implications in this Level 3 cohort.
Previous investigations suggested that heparin administration to humans enhances the tissue type plasminogen activator (tPA) levels in blood, but it remains uncertain whether this effect induces fibrinolysis. We studied the effect of therapeutic levels of heparinization on plasma markers for fibrinolysis in patients suspected of pulmonary embolism (PE). Blood samples were taken from 49 consecutive patients; 28 had confirmed PE, 21 had PE excluded. On admission, the plasma levels of plasmin-alpha 2antiplasmin complexes and D-dimer were significantly higher in the patient group with PE compared to those in whom PE was excluded. After heparinization the tPA levels increased in both groups, showing that this effect was not dependent on the initial level of activity of fibrinolysis. In spite of this increment in tPA levels, the concentrations of plasmin-alpha 2antiplasmin complexes and D-dimer decreased. In conclusion, although heparinization in patients with or without pulmonary embolism does lead to elevated tPA:Ag levels, this is not accompanied by enhanced fibrinolysis.
No takes yet. Share an insight, caveat, or question.
Minnema et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: